文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

Presepsin对重症急性胰腺炎ICU患者继发性脓毒症及死亡率的早期预测价值

EARLY PREDICTIVE VALUE OF PRESEPSIN FOR SECONDARY SEPSIS AND MORTALITY IN INTENSIVE CARE UNIT PATIENTS WITH SEVERE ACUTE PANCREATITIS.
PubMed 文献 · Shock · 2023-02-01
一句话结论在重症急性胰腺炎ICU患者中,第3天presepsin是继发性脓毒症及ICU出院、第28天和第90天死亡率的独立相关标志物,预测准确性不劣于或优于降钙素原和SOFA评分。

本研究为回顾性研究,纳入48例脓毒症患者和53例非脓毒症患者,均为因重症急性胰腺炎入住ICU者。检测入组后第1、3、7天的presepsin及其他血液标志物(降钙素原、C反应蛋白、IL-6、白细胞、血清肌酐)和评分系统,以预测继发性脓毒症,并在ICU出院、第28天和第90天评估结局。脓毒症组第1、3、7天presepsin水平显著高于非脓毒症组,且两组均呈上升趋势,但脓毒症组上升更快。第3天和第7天presepsin是唯一与重症急性胰腺炎继发性脓毒症独立相关的血液标志物,第3天presepsin与ICU出院、第28天和第90天死亡率独立相关。作者认为presepsin可能是重症急性胰腺炎ICU患者继发性脓毒症和死亡率的有价值早期预测指标,并可能作为早期风险分层的指标。

要点

  • 脓毒症组第1、3、7天presepsin水平均显著高于非脓毒症组,且脓毒症组上升速度更快。
  • 第3天和第7天presepsin是唯一与重症急性胰腺炎继发性脓毒症独立相关的血液标志物。
  • 第3天presepsin与ICU出院、第28天和第90天死亡率独立相关。
  • presepsin对继发性脓毒症和死亡率的预测准确性不劣于或优于降钙素原和SOFA评分。
  • 作者认为presepsin可能作为重症急性胰腺炎ICU患者早期风险分层的指标。

适用人群与场景

  • 因重症急性胰腺炎入住ICU的患者,包括48例脓毒症患者和53例非脓毒症患者。

研究设计与关键结果

  • 回顾性研究纳入48例脓毒症患者和53例非脓毒症患者,均为因重症急性胰腺炎入住ICU者。
  • 检测入组后第1、3、7天的presepsin及其他血液标志物(降钙素原、C反应蛋白、IL-6、白细胞、血清肌酐)和评分系统。
  • 脓毒症组第1、3、7天presepsin水平显著高于非脓毒症组。
  • 两组presepsin水平随时间均呈上升趋势,但脓毒症组上升速度快于非脓毒症组。
  • 第3天和第7天presepsin是唯一与重症急性胰腺炎继发性脓毒症独立相关的血液标志物。
  • 第3天presepsin与ICU出院、第28天和第90天死亡率独立相关。
  • presepsin对继发性脓毒症和死亡率的预测准确性不劣于或优于降钙素原和SOFA评分。

证据类型、等级与局限

  • 证据类型:回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为presepsin可能是重症急性胰腺炎ICU患者继发性脓毒症和死亡率的有价值早期预测指标,并可能作为早期风险分层的指标。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Purpose : Sepsis is the leading cause of death in patients with severe acute pancreatitis (SAP) in the intensive care unit (ICU). Early prediction of sepsis secondary to SAP developed in the late phase and of related mortality can enable appropriate treatment and improve outcomes. This study was conducted to evaluate the predictive value of presepsin in ICU patients with SAP at the early stage and compared it with established blood markers and scoring systems. Methods : This retrospective study enrolled 48 septic patients and 53 nonseptic patients admitted to ICU with SAP. Presepsin and other blood markers (procalcitonin, C-reactive protein, IL-6, white blood cell, and serum creatinine) on days 1, 3, and 7 after enrollment as well as scoring systems were assessed to predict secondary sepsis. Outcomes were evaluated at ICU discharge and on days 28 and 90. Results : Presepsin levels (on days 1, 3, and 7) were significantly higher in septic patients than in nonseptic patients. Presepsin levels showed an increasing trend over time in both sepsis and nonsepsis groups, but concentrations increased more rapidly in the sepsis group than in the nonsepsis group. Among the analyzed biomarkers, presepsin was the only blood marker independently associated with sepsis secondary to SAP on days 3 and 7, and presepsin on day 3 was independently associated with mortality at ICU discharge and on days 28 and 90. It showed similar or even better predictive accuracy for both secondary sepsis and mortality than procalcitonin and Sequential Organ Failure Assessment score. Conclusion : Presepsin could be a valuable early predictor of secondary sepsis and mortality in patients admitted to the ICU with SAP and may serve as an indicator for early risk stratification.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Wang C, Zhang J, Liu L, et al. EARLY PREDICTIVE VALUE OF PRESEPSIN FOR SECONDARY SEPSIS AND MORTALITY IN INTENSIVE CARE UNIT PATIENTS WITH SEVERE ACUTE PANCREATITIS. Shock. 2023. PMID: 36719429. doi:10.1097/SHK.0000000000002088

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。